Aude Boignard

ORCID: 0000-0001-5345-9905
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mechanical Circulatory Support Devices
  • Cardiac Structural Anomalies and Repair
  • Systemic Sclerosis and Related Diseases
  • Cardiac Arrest and Resuscitation
  • Transplantation: Methods and Outcomes
  • Heart Failure Treatment and Management
  • Thermoregulation and physiological responses
  • Cardiac Valve Diseases and Treatments
  • Aortic Disease and Treatment Approaches
  • Pulmonary Hypertension Research and Treatments
  • Infrared Thermography in Medicine
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Cardiovascular Function and Risk Factors
  • Congenital Heart Disease Studies
  • COVID-19 Impact on Reproduction
  • Cardiovascular Issues in Pregnancy
  • Cardiac Imaging and Diagnostics
  • Cardiac pacing and defibrillation studies
  • Cardiac Arrhythmias and Treatments
  • SARS-CoV-2 and COVID-19 Research
  • Cerebrovascular and Carotid Artery Diseases
  • Cytomegalovirus and herpesvirus research
  • Herpesvirus Infections and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Coronary Interventions and Diagnostics

Centre Hospitalier Universitaire de Grenoble
2004-2024

Université Grenoble Alpes
2004-2024

Société Française de Cardiologie
2024

Hôpital Albert Michallon
2002-2023

Centre d'Investigation Clinique - Innovation Technologique
2020

Inserm
2004-2007

University of Oregon
2006

Université Joseph Fourier
2002

Frederiek de Heer Jolanda Kluin Gébrine Elkhoury Guillaume Jondeau Maurice Enríquez-Sarano and 95 more Hans‐Joachim Schäfers Johanna J.M. Takkenberg Emmanuel Lansac Christian Dinges Johannes Steindl Rosina Ziller Laurent De Kerchove Taoufik Benkacem C Coulon Gébrine Elkhoury Fadoua Kaddouri Jean‐Louis Vanoverschelde Christophe de Meester Agnès Pasquet Jan Nijs Veerle Van Mosselvelde Bart Loeys Bart Meuris Evi Schepmans Klaartje Van den Bossche Peter Verbrugghe Wenke Goossens Herbert Gutermann Matteo Pettinari Ismaı̈l El-Hamamsy Marien Lenoir Pierre‐Emmanuel Noly Michaël Tousch Pallav Shah Munir Boodhwani Igor Rudež Davor Barić Daniel Unić Josip Varvodić Savica Gjorgijevska Jan Vojáček Pavel Žáček Mikita Karalko Jaroslav Hlubocký Róbert Novotný Andrey Slautin Said Soliman Eric Arnaud-Crozat Aude Boignard Georges Fayad Olivier Bouchot Bernard Albat Alain Leguerrier Fabien Doguet Jean‐François Fuzellier Y Glock Guillaume Jondeau Guy Fernandez Didier Chatel David Messika–Zeitoun Jérôme Jouan Isabelle Di Centa Jean‐François Obadia Pascal Leprince Rémi Houël Eric Bergoënd Stéphane Lopez Alain Berrébi Florence Tubach Emmanuel Lansac Stéphanie Lejeune Jean‐Luc Monin Sarah Pousset Leila Mankoubi Milean Noghin Christelle Diakov Daniel Czytrom Hans‐Joachim Schäfers Michael A. Borger Diana Aicher Frank Theisohn Paolo Ferrero Șerban Stoica Maciej Matuszewski Patrick Yiu Mohamad Bashir Fabrizio Ceresa Francesco Patanè Ruggero De Paulis Ilaria Chirichilli Mauro Masat Carlo Antona Monica Contino Andrea Mangini Claudia Romagnoni Francesco Grigioni Rubina Rosa Yutaka Okita Takeshi Miyairi Takashi Kunihara

10.1016/j.jtcvs.2018.10.076 article EN publisher-specific-oa Journal of Thoracic and Cardiovascular Surgery 2018-10-26

Abstract Accurate and sensitive measurement techniques are a key issue in the quantification of microvascular endothelial dysfunction systemic sclerosis (SSc). Thermal hyperhemia comprises two separate mechanisms: an initial peak that is axon reflex mediated; sustained plateau phase nitric oxide dependent. The main objective our study was to test whether thermal patients with SSc differed from primary Raynaud's phenomenon (RP) healthy controls. In first study, we enrolled 20 suffering SSc,...

10.1186/ar1785 article EN cc-by Arthritis Research & Therapy 2005-07-19

Barth E, Durand M, Heylbroeck C, Rossi‐Blancher Boignard A, Vanzetto G, Albaladejo P, Chavanon O. Extracorporeal life support as a bridge to high‐urgency heart transplantation. Clin Transplant 2011 DOI: 10.1111/j.1399‐0012.2011.01525.x. © John Wiley & Sons A/S. Abstract: (ECLS) represents an effective, emergent therapy for patients with end‐stage failure or cardiac arrest. However, ECLS is typically not used transplantation because of the limited duration ECLS. In France, priority...

10.1111/j.1399-0012.2011.01525.x article EN Clinical Transplantation 2011-09-15

Abstract Aims Heart transplantation (HT) can be proposed as a therapeutic strategy for patients with severe refractory electrical storm (ES). Data in the literature are scarce and based on case reports. We aimed at determining characteristics survival of transplanted ES. Methods results Patients registered HT waiting list during following days after ES eventually transplanted, from 2010 to 2021, were retrospectively included 11 French centres. The primary endpoint was in-hospital mortality....

10.1093/ehjacc/zuad063 article EN European Heart Journal Acute Cardiovascular Care 2023-06-15

Objectives Cytomegalovirus (CMV) is frequently detected in lung and/or blood samples of patients with Pneumocystis jirovecii pneumonia (PJP), although this co-detection not precisely understood. We aimed to determine whether PJP was more severe case CMV detection. Methods retrospectively included all a diagnosis between 2009 and 2020 our centre measure viral load bronchoalveolar lavage (BAL). severity assessed by the requirement for intensive care unit (ICU) admission. Results The median age...

10.1371/journal.pone.0296758 article EN cc-by PLoS ONE 2024-01-10

BackgroundPrediction of outcomes remains an unmet need in LVAD candidates. Development right heart failure portends excess mortality but imaging parameters ventricular systolic function have failed to demonstrate a prognostic role. By integrating pulmonary pressure, ventriculoarterial coupling could fill this gap.MethodsThe ASSIST-ICD registry was used test surrogate at implantation for the prediction all-cause mortality.ResultsThe ratio tricuspid annular plane excursion over estimated...

10.1016/j.cardfail.2024.05.007 article EN cc-by-nc-nd Journal of Cardiac Failure 2024-06-01

The value of Forrester's perfusion/congestion profiles assessed by invasive catheter evaluation in non-inotrope advanced heart failure patients listed for transplant (HT) is unclear. We aimed to assess the haemodynamic according predict events on HT waitlist.

10.1002/ehf2.14037 article EN ESC Heart Failure 2022-07-07

Objectives. Thermal hyperaemia is impaired in patients with systemic sclerosis (SSc). The objective of these studies was to determine whether this consecutive skin fibrosis, microangiopathy or macroangiopathy. Methods. Using laser Doppler flowmetry, we first compared the thermal on third left finger pad and forearm 21 non-diffuse (SSc), comparison primary Raynaud's phenomenon healthy volunteers. Second, tested altered correlated digital pressure index at baseline, following challenge....

10.1093/rheumatology/kel116 article EN Lara D. Veeken 2006-05-16

Postoperative pericardial effusion is frequent and can be complicated by cardiac tamponade. Although the different drainage techniques are well described in setting of medical effusion, there not a standard postoperative treatment. The aim this work was to assess feasibility effectiveness percutaneous drainage.This retrospective study involving 197 patients from 1990 2008. Drainage performed subxiphoid puncture (91.9%) or left parasternal (8.1%) between 3 690 days following procedure via...

10.1111/j.1540-8183.2011.00680.x article EN Journal of Interventional Cardiology 2011-10-10

Abstract OBJECTIVES Our goal was to provide a picture of left ventricular assist device (LVAD) activity in France between 2007 and 2016 based on the multicentric ASSIST-ICD registry. METHODS We retrospectively collected 136 variables including in-hospital data, follow-up survival rates adverse events from 671 LVAD recipients at 20 out 24 implant centres France. The average time 1.2 years (standard deviation: 1.4); total 807.5 patient-years. RESULTS included devices were HeartMate II®,...

10.1093/ejcts/ezaa055 article EN European Journal of Cardio-Thoracic Surgery 2020-02-05

Letermovir, an anti-cytomegalovirus (CMV) drug, is recommended as a prophylactic agent in patients at risk of CMV infection/reactivation after allogeneic hematopoietic stem cell transplant. We report the curative and pre-emptive use letermovir two heart transplant recipients. In one patient with ganciclovir-resistant CMV, was successfully used to treat colitis. second patient, therapy for reactivation, but did not prevent esophagitis. both cases, successful secondary prophylaxis. Curative...

10.1177/13596535221133619 article EN cc-by-nc Antiviral Therapy 2022-11-18

Temporary circulatory support (TCS) as a bridge-to-left ventricular assist device (BTL) in cardiogenic shock patients has been increasing, but limited data exists on this BTL strategy. We aimed at analyzing the outcome of population compared with those without TCS time left (LVAD) surgery and identify predictors postoperative mortality specific population.A multicenter retrospective observational study conducted 19 centers from 2006 to 2016.Nineteen French centers.A total 329 LVAD...

10.1097/ccm.0000000000005424 article EN Critical Care Medicine 2022-01-02
Coming Soon ...